FLASH: P&T Changes at April Meeting
April 15, 2025Pharmacy Updates
Effective April 1, 2025, Stelara (ustekinumab) will be a nonformulary medication, and all non-Medicare patients will need to switch to an ustekinumab biosimilar for covered treatment.
Carle Health has announced after careful consideration, as of January 1, 2026, our health plans will cease operating all lines of business except for Medicare Advantage.
FLASH: Recent Calls regarding select codes removed from Prior Authorization requirements effective 1/1/2025